Exploring the convergence of nanotechnology, biotechnology and AI in transforming cancer treatment during the Fourth Industrial Revolution
Exploring the legal challenges posed by rapid advancements in genetic engineering, AI-powered biology, and nanotechnology
Examining whether India's Bureau of Indian Standards (BIS) has the precision, enforceability, and global credibility to become a true global gold standard.
Explore how green carbon dots derived from natural sources are transforming biomedical applications with sustainable nanotechnology.
Exploring how cell-free DNA is transforming cancer diagnostics and therapeutic monitoring through liquid biopsies.
Exploring how next-generation sequencing and flow cytometry are transforming minimal residual disease detection in multiple myeloma treatment.
Exploring how biomarkers are transforming the economics of oncology drug development through precision medicine approaches.
The scientific breakthrough behind Zokinvy (lonafarnib), the first FDA-approved drug for Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic aging disease.
Discover how plant-derived cyclotides are being engineered to target Hdm2/HdmX and restore p53 function in cancer therapy.
Exploring the groundbreaking 'Cancer Genetics Report' section in JJCO and its impact on personalized cancer medicine in the post-sequencing age.